FDA Inspection
Taizhou Xianju Pharmaceutical Co. Ltd.Taizhou Xianju Pharmaceutical Co. Ltd. – FDA Inspection, Mar 31, 2017
Record Details
This FDA Inspection record concerns Taizhou Xianju Pharmaceutical Co. Ltd., with an inspection on March 31, 2017, issued by the Center for Drug Evaluation and Research, covering drugs.
View Company Profile
ID · c928eb35-fe18-41ef-b120-6c5e93656bb3
Inspection Facts
Voluntary Action Indicated (VAI)
Objectionable conditions were found, but FDA is not prepared to take or recommend regulatory action.
- Inspection number
- 1009605
- FDA center
- Human Drugs
- Project area
- Drug Quality Assurance
- Outcome
- Form 483 issued
Other FDA inspections of Taizhou Xianju Pharmaceutical Co. Ltd.
1| Date | Classification | Office | Project area |
|---|---|---|---|
| November 15, 2024 | NAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
Other documents for Taizhou Xianju Pharmaceutical Co. Ltd.
- FDA Inspection 1256835 - 2024-11-15
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.